Clips / Mushrooms for the Mind & Immune System | Paul Stamets
We had more non -microdosers than we had microdozers in the study, 4,500, like non -microdosers, a few…
0:39 · 1:48:35–1:49:14 in the episode · Paul Stamets
“We had more non -microdosers than we had microdozers in the study, 4,500, like non -microdosers, a few hundred less microdosers.”
In context
Full transcript →-
to a particular frequency.
-
of sound. I mean, that's not uncommon, right, which is a form of synesthesia.
-
May I ask about the benefits and any potential side effects that were observed in this
-
study on microdosing? Because I know it's one of the few large subject number studies of
-
microdosing, and I know you were involved in this study, so I just would love to highlight that
-
for people. Well, yes, I was to my colleagues, this quantified citizen out of British Columbia.
-
I think we got up to 25,000 participants. We published two papers in nature.
-
The scientific reports, observational studies, these are self-reporting.
-
They were given, basically, they enrolled.
-
They created a baseline and the motivation, why you're taking salsai mushrooms,
-
how much you're taking, what are you combining it with, et cetera.
-
The first paper we published in nature, we heard back to the editors,
-
what they really liked about it is the two groups are so well-weighted.
-
We had more non-microdosers than we had microdozers in the study,
-
4,500, like non-microdosers, a few hundred less microdosers.
-
So that was extraordinary.
-
People were motivated to do a test, and we had more non-dosers.
-
And I thought, well, maybe they're trying to create their baselines, you know, or something like that.
-
You know, I would, you're a little citizen scientist, you know, this is a citizen scientist effort.
-
So that may indeed be what was happening.
-
But of course, the results showed tremendous improvement against depression and PTSD.
-
DSD and anxiety, those are the ones that really were significant in the measurements.